Rosmarinic acid study points to shrimp health, growth benefits
Bottom line
A new study in Animals reports that adding rosmarinic acid, a plant-derived polyphenol, to feed improved growth, feed efficiency, immune markers, antioxidant capacity, and resistance to Vibrio parahaemolyticus challenge in Pacific white shrimp (Litopenaeus vannamei). In the eight-week trial, shrimp fed the highest tested inclusion level, 450 mg/kg, showed higher weight gain and lower feed conversion ratio than controls, while transcriptomic analysis of the hepatopancreas suggested the additive may work through immune- and metabolism-related pathways. The work adds to a growing body of aquaculture nutrition research evaluating phytogenic compounds as alternatives to antibiotic-dependent disease management in shrimp production. (aquadisease.com)
Why it matters: For veterinary and aquaculture professionals, the study is another signal that phytogenic feed additives are moving beyond simple growth-promotion claims and toward measurable effects on disease resilience, oxidative stress, and host biology. That said, this is still an early-stage feeding study, not a field validation. Practical adoption will depend on repeatability under commercial conditions, cost per ton of feed, regulatory fit in target markets, and whether benefits hold up across different disease pressures and formulations. (aquadisease.com)
What to watch: Watch for follow-up trials in commercial ponds, dose-optimization work, and any move to position rosmarinic acid within broader phytogenic or functional-feed programs. (aquadisease.com)
A study published in Animals says dietary rosmarinic acid may improve both performance and health outcomes in Pacific white shrimp, one of the world’s most important farmed shrimp species. According to the paper, shrimp fed rosmarinic acid for eight weeks showed gains in growth, feed efficiency, immune response, antioxidant status, and survival after Vibrio parahaemolyticus challenge, with the strongest performance reported in the 450 mg/kg group. (aquadisease.com)
The finding lands in a familiar but important part of aquaculture nutrition: the search for feed-based tools that can reduce reliance on antibiotics while helping producers manage chronic disease pressure. Vibrio parahaemolyticus remains a major pathogen in shrimp systems, and a wide range of plant extracts, essential oils, organic acids, tannins, and other phytogenic additives have been studied as possible preventive tools. Recent and prior studies in L. vannamei have similarly tested olive leaf extract, essential-oil blends, and other phytobiotic formulations for effects on growth, gut health, antioxidant function, and resistance to Vibrio challenge. (mdpi.com)
In the rosmarinic acid study, researchers tested four diets containing 0, 50, 150, and 450 mg/kg rosmarinic acid in shrimp starting at about 1.8 g body weight. Based on the study summary, the highest-dose group achieved significantly higher weight gain and lower feed conversion ratio than the control. The paper also reported improved serum immune and antioxidant indicators, along with hepatopancreatic transcriptomic changes intended to clarify potential mechanisms behind the response. The challenge component, using V. parahaemolyticus, is especially relevant because it moves the work beyond growth alone and into disease resilience, which is where many pet food and animal nutrition innovations ultimately need to prove value. (aquadisease.com)
There’s also a plausible biological rationale for the result. Rosmarinic acid is already known for antioxidant and antimicrobial-related properties in other contexts, and separate published work has reported bacteriostatic effects when rosmarinic acid was tested against Vibrio species in vitro. More broadly, a recent npj Science of Food paper found that Perilla frutescens powder, described by the authors as enriched in rosmarinic acid and flavonoids, improved immune and antioxidant responses and reduced mortality and bacterial load in shrimp challenged with AHPND-causing V. parahaemolyticus. That doesn’t prove rosmarinic acid alone caused the benefit in either study, but it does support the broader idea that rosmarinic-acid-containing phytogenics may have practical relevance in shrimp health programs. (pubmed.ncbi.nlm.nih.gov)
I didn’t find substantial independent expert commentary tied specifically to this new paper, but the surrounding literature shows clear industry and research interest in phytogenic disease-management strategies for shrimp. Multiple studies have reported improved growth, immune markers, antioxidant capacity, or post-challenge survival with plant-derived additives, though the effective compounds, inclusion rates, and magnitude of benefit vary considerably. That variability is important: it suggests formulation, dose, background diet, culture conditions, and pathogen pressure all likely shape real-world outcomes. (sciencedirect.com)
Why it matters: For veterinary professionals working in aquaculture, this study reinforces a broader shift toward functional feeds that aim to support host resilience rather than only target pathogens directly. If the results are reproducible, rosmarinic acid could become another candidate ingredient for health-support diets in shrimp, especially where producers are trying to balance performance, biosecurity, and reduced antimicrobial inputs. But the usual caveats apply: controlled feeding trials often look cleaner than commercial pond conditions, and transcriptomic signals don’t automatically translate into consistent economic return. Questions around ingredient sourcing, stability in feed manufacture, target inclusion rates, and regulatory positioning still matter as much as the biology. (aquadisease.com)
The study may also be useful as a marker of where aquaculture nutrition science is headed. Researchers increasingly pair production endpoints with omics data, microbiome work, and pathogen challenge models to make a stronger case for mechanism. That can help feed companies and veterinarians distinguish between additives that merely correlate with better performance and those that appear to affect immune signaling, oxidative balance, or gut and hepatopancreatic health in a more defined way. (aquadisease.com)
What to watch: The next step is whether rosmarinic acid is validated in larger commercial trials, compared head-to-head with other phytogenic strategies, or incorporated into multi-ingredient functional feeds. Watch, too, for more detail on optimal dose, consistency across production systems, and whether regulators and feed manufacturers treat purified rosmarinic acid differently from botanical ingredients that naturally contain it. (aquadisease.com)
Common questions
What did the study find about rosmarinic acid in shrimp feed?
In an eight-week trial, shrimp fed rosmarinic acid showed better growth, feed efficiency, immune response, antioxidant status, and survival after Vibrio parahaemolyticus challenge, with the strongest results at 450 mg/kg.What dose worked best in the study?
The highest tested inclusion level, 450 mg/kg, showed significantly higher weight gain and lower feed conversion ratio than the control.Does this mean rosmarinic acid is ready for commercial use?
No. The article says this is an early-stage feeding study, not a field validation, and that commercial adoption will depend on repeatability, cost, regulatory fit, and whether benefits hold under different conditions.What kind of shrimp were studied?
Pacific white shrimp, Litopenaeus vannamei.